{"transactions":[{"id":4637423,"issuer":{"id":4122,"kind":"organization","name":"GRAIL, Inc.","symbol":"GRAL"},"owners":[{"id":40794,"kind":"person","name":"Partridge Andrew John","position":1,"cik":"0001758838","reported_name":"Partridge Andrew John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Growth Officer"}}],"security":"Common Stock","published_at":"2026-10-07T22:36:29.000Z","date":"2026-10-05","kind":"sale","planned":false,"acquired":false,"shares":7873,"price":146.39,"value":1152528.47,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents automatic 'sell-to-cover' transactions by an executing broker to cover withholding taxes upon award vesting and share delivery. The price reported in Column 4 is a weighted average price calculated by the broker executing these transactions. These shares were sold as part of a block trade in multiple transactions, and the Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate sales price."}],"balance_after":155865,"source":{"system":"sec-edgar","filing":"0001628280-26-065365","document":"wk-form4_1791412587.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1758838/000162828026065365/wk-form4_1791412587.xml","form_type":"4"}},{"id":747431,"issuer":{"id":4122,"kind":"organization","name":"GRAIL, Inc.","symbol":"GRAL"},"owners":[{"id":40794,"kind":"person","name":"Partridge Andrew John","position":1,"cik":"0001758838","reported_name":"Partridge Andrew John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Growth Officer"}}],"security":"Common Stock","published_at":"2026-06-06T00:16:22.000Z","date":"2026-06-04","kind":"sale","planned":false,"acquired":false,"shares":1491,"price":61.08,"value":91070.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents automatic 'sell-to-cover' transactions by an executing broker to cover withholding taxes upon award vesting and share delivery. The price reported in Column 4 is a weighted average price calculated by the broker executing these transactions. These shares were sold as part of a block trade in multiple transactions, and the Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate sales price."}],"balance_after":163738,"source":{"system":"sec-edgar","filing":"0001628280-26-041356","document":"wk-form4_1780704979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699031/000162828026041356/wk-form4_1780704979.xml","form_type":"4"}},{"id":2400945,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":40794,"kind":"person","name":"Partridge Andrew John","position":1,"cik":"0001758838","reported_name":"Partridge Andrew John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-11T18:09:59.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":58600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares vest monthly following February 9, 2022."}],"balance_after":58600,"derivative":{"exercise_price":37.68,"expiration_date":"2032-02-08","underlying":"Common Stock","underlying_shares":58600},"source":{"system":"sec-edgar","filing":"0001209191-22-008983","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919122008983/doc4.xml","form_type":"4"}},{"id":2400944,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":40794,"kind":"person","name":"Partridge Andrew John","position":1,"cik":"0001758838","reported_name":"Partridge Andrew John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-02-11T18:09:59.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":16283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted stock unit award granted under the Issuer's 2019 Equity Plan."}],"balance_after":38361,"source":{"system":"sec-edgar","filing":"0001209191-22-008983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919122008983/doc4.xml","form_type":"4"}},{"id":2400943,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":40794,"kind":"person","name":"Partridge Andrew John","position":1,"cik":"0001758838","reported_name":"Partridge Andrew John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-02-11T18:09:59.000Z","date":"2022-02-09","kind":"sale","acquired":false,"shares":221,"price":36.3,"value":8022.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to Reporting Person on February 8, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 199 shares on June 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan (the \"ESPP\") and 333 shares on December 10, 2021 pursuant to the ESPP."}],"balance_after":22078,"source":{"system":"sec-edgar","filing":"0001209191-22-008983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919122008983/doc4.xml","form_type":"4"}},{"id":2632942,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":40794,"kind":"person","name":"Partridge Andrew John","position":1,"cik":"0001758838","reported_name":"Partridge Andrew John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-07-15T17:53:20.000Z","date":"2021-07-14","kind":"sale","acquired":false,"shares":1869,"price":74.9,"value":139988.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares of common stock to cover tax withholding obligations associated with vesting of a restricted stock unit award granted to Reporting Person on July 13, 2020."}],"balance_after":21767,"source":{"system":"sec-edgar","filing":"0001209191-21-046809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919121046809/doc4.xml","form_type":"4"}},{"id":2868512,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":40794,"kind":"person","name":"Partridge Andrew John","position":1,"cik":"0001758838","reported_name":"Partridge Andrew John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Stock Option (right  to buy)","published_at":"2021-02-10T17:59:43.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":9733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares vest monthly following February 8, 2021."}],"balance_after":9733,"derivative":{"exercise_price":140.01,"expiration_date":"2031-02-07","underlying":"Common Stock","underlying_shares":9733},"source":{"system":"sec-edgar","filing":"0001209191-21-009371","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919121009371/doc4.xml","form_type":"4"}},{"id":2868511,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":40794,"kind":"person","name":"Partridge Andrew John","position":1,"cik":"0001758838","reported_name":"Partridge Andrew John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-02-10T17:59:43.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":2136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan."}],"balance_after":23636,"source":{"system":"sec-edgar","filing":"0001209191-21-009371","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919121009371/doc4.xml","form_type":"4"}},{"id":3083271,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":40794,"kind":"person","name":"Partridge Andrew John","position":1,"cik":"0001758838","reported_name":"Partridge Andrew John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-14T17:40:40.000Z","date":"2020-07-13","kind":"grant","acquired":true,"shares":127500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on July 13, 2021 and 1/48th of the shares vest monthly thereafter over the next three years."}],"balance_after":127500,"derivative":{"exercise_price":59.94,"expiration_date":"2030-07-12","underlying":"Common Stock","underlying_shares":127500},"source":{"system":"sec-edgar","filing":"0001209191-20-042407","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120042407/doc4.xml","form_type":"4"}},{"id":3083270,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":40794,"kind":"person","name":"Partridge Andrew John","position":1,"cik":"0001758838","reported_name":"Partridge Andrew John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-07-14T17:40:40.000Z","date":"2020-07-13","kind":"grant","acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan."}],"balance_after":21500,"source":{"system":"sec-edgar","filing":"0001209191-20-042407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595893/000120919120042407/doc4.xml","form_type":"4"}}]}